Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.28 USD | +11.30% | -10.49% | +88.24% |
Jun. 05 | IMUNON, Inc. Announces First Participants Vaccinated in IMNN-101 Phase 1 Clinical Trial | CI |
May. 20 | Imunon, Inc. Announces CFO Changes, Effective from June 1, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+88.24% | 10.81M | |
+18.34% | 125B | |
+15.06% | 108B | |
-6.39% | 23.64B | |
+2.39% | 22.39B | |
-12.11% | 17.78B | |
-41.64% | 16.43B | |
-12.07% | 16.34B | |
+1.05% | 13.56B | |
+25.87% | 11.59B |
- Stock Market
- Equities
- IMNN Stock
- News Imunon, Inc.
- Imunon Strikes Deal For Preclinical Studies in Vaccines Against Lassa Virus